» Articles » PMID: 37553791

Elevated Serum Uric Acid is a Risk Factor for Progression to Prediabetes in Japanese Women: A 5-year Retrospective Chort Study

Overview
Specialty Endocrinology
Date 2023 Aug 9
PMID 37553791
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/introduction: The association between serum uric acid (SUA) levels and prediabetes risk remains poorly understood. The aim of this longitudinal retrospective study was to evaluate the association between SUA levels and prediabetes progression in Japanese individuals through sex-specific analysis.

Materials And Methods: We enrolled 20,743 participants (11,916 men and 8,827 women) who underwent annual medical health checkups in 2017 (baseline) and 2022. None of the participants had diabetes and prediabetes or were taking SUA-lowering medications at baseline. Participants were divided into four groups according to the quartiles of SUA levels at baseline. Multivariable-adjusted Cox regression analysis was conducted to examine the risk of prediabetes progression. In addition, multivariate restricted cubic spline analysis was conducted to investigate the dose-response risk.

Results: In women, compared with the lowest SUA quartile (Q1) group, the adjusted hazard ratios (95% confidence intervals) of prediabetes in the Q2, Q3, and Q4 groups were 1.03 (0.86-1.25), 1.41 (1.18-1.68), and 1.55 (1.30-1.84), respectively. However, in men, no significant association in the risk of prediabetes was found across quartiles of SUA. Furthermore, in women, restricted cubic spline analysis revealed the dose-response relationship between SUA and progression to prediabetes.

Conclusions: The results indicate that elevated serum SUA levels might be positively and independently associated with an increased risk of progression to prediabetes in Japanese women.

Citing Articles

Association between serum uric acid and prediabetes in a normal Chinese population: A cross-sectional study.

Shen K, Huang Y, Zhang J, Chen L, Cai X, Pan J Medicine (Baltimore). 2024; 103(48):e40544.

PMID: 39612437 PMC: 11608712. DOI: 10.1097/MD.0000000000040544.

References
1.
Minooee S, Ramezani Tehrani F, Rahmati M, Amanollahi Soudmand S, Tohidi M, Sabet Z . The association between serum total testosterone and progression of hyperglycemia: a 15-year prospective cohort study. Andrology. 2019; 7(2):148-155. DOI: 10.1111/andr.12568. View

2.
Feig D, Kang D, Johnson R . Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17):1811-21. PMC: 2684330. DOI: 10.1056/NEJMra0800885. View

3.
Yahyaoui R, Esteva I, Haro-Mora J, Almaraz M, Morcillo S, Rojo-Martinez G . Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab. 2008; 93(6):2230-3. DOI: 10.1210/jc.2007-2467. View

4.
Chen N, Muhammad I, Li Z, Nilsson P, Borne Y . Sex-Specific Associations of Circulating Uric Acid with Risk of Diabetes Incidence: A Population-Based Cohort Study from Sweden. Diabetes Metab Syndr Obes. 2020; 13:4323-4331. PMC: 7669519. DOI: 10.2147/DMSO.S273387. View

5.
. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2020; 44(Suppl 1):S15-S33. DOI: 10.2337/dc21-S002. View